Cargando…

Gateways for Glutamate Neuroprotection in Parkinson’s Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD

Increasing evidence suggests that metabolic alterations may be etiologically linked to neurodegenerative disorders such as Parkinson’s disease (PD) and in particular empathizes the possibility of targeting mitochondrial dysfunctions to improve PD progression. Under different pathological conditions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piccirillo, Silvia, Magi, Simona, Preziuso, Alessandra, Castaldo, Pasqualina, Amoroso, Salvatore, Lariccia, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563499/ https://www.ncbi.nlm.nih.gov/pubmed/32899900 http://dx.doi.org/10.3390/cells9092037

Ejemplares similares

Essential role of the Na(+)-Ca2(+) exchanger (NCX) in glutamate-enhanced cell survival in cardiac cells exposed to hypoxia/reoxygenation
por: Maiolino, Marta, et al.
Publicado: (2017)

Excitatory Amino Acid Transporters (EAATs): Glutamate Transport and Beyond
por: Magi, Simona, et al.
Publicado: (2019)

Exploring the Role of NCX1 and NCX3 in an In Vitro Model of Metabolism Impairment: Potential Neuroprotective Targets for Alzheimer’s Disease
por: Preziuso, Alessandra, et al.
Publicado: (2023)

Physical and Functional Interaction of NCX1 and EAAC1 Transporters Leading to Glutamate-Enhanced ATP Production in Brain Mitochondria
por: Magi, Simona, et al.
Publicado: (2012)

Glutamate as a potential “survival factor” in an in vitro model of neuronal hypoxia/reoxygenation injury: leading role of the Na(+)/Ca(2+) exchanger
por: Piccirillo, Silvia, et al.
Publicado: (2018)

A new K(+)channel-independent mechanism is involved in the antioxidant effect of XE-991 in an in vitro model of glucose metabolism impairment: implications for Alzheimer’s disease
por: Piccirillo, Silvia, et al.
Publicado: (2022)

The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease
por: Magi, Simona, et al.
Publicado: (2021)

The Hidden Notes of Redox Balance in Neurodegenerative Diseases
por: Piccirillo, Silvia, et al.
Publicado: (2022)

Selective inhibition of mitochondrial sodium-calcium exchanger protects striatal neurons from α-synuclein plus rotenone induced toxicity
por: Bastioli, Guendalina, et al.
Publicado: (2019)

Glutamate Transporters EAAT4 and EAAT5 Are Expressed in Vestibular Hair Cells and Calyx Endings
por: Dalet, Antoine, et al.
Publicado: (2012)

Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
por: Magi, Simona, et al.
Publicado: (2016)

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
por: Parkin, Georgia M, et al.
Publicado: (2018)

Glutamate Transporters EAAT2 and EAAT5 Differentially Shape Synaptic Transmission from Rod Bipolar Cell Terminals
por: Tang, Fu-Sheng, et al.
Publicado: (2022)

Molecular Dynamics Simulations of the Mammalian Glutamate Transporter EAAT3
por: Heinzelmann, Germano, et al.
Publicado: (2014)

The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder
por: Escobar, Angélica P., et al.
Publicado: (2019)

Effects of tranexamic acid on the activity of glutamate transporter EAAT3
por: Shin, Hyun-Jung, et al.
Publicado: (2020)

EAAT5 Glutamate Transporter-Mediated Inhibition in the Vertebrate Retina
por: Lukasiewcz, Peter D., et al.
Publicado: (2021)

The Glutamate Transporter Subtypes EAAT4 and EAATs 1-3 Transport Glutamate with Dramatically Different Kinetics and Voltage Dependence but Share a Common Uptake Mechanism
por: Mim, Carsten, et al.
Publicado: (2005)

LRET-based distance measurements in the mammalian glutamate transporter EAAT3
por: Saha, Kusumika, et al.
Publicado: (2012)

Impaired K(+) binding to glial glutamate transporter EAAT1 in migraine
por: Kovermann, Peter, et al.
Publicado: (2017)

Blood glutamate EAAT(2)-cell grabbing therapy in cerebral ischemia
por: Pérez-Mato, María, et al.
Publicado: (2018)

Shaping of Signal Transmission at the Photoreceptor Synapse by EAAT2 Glutamate Transporters
por: Niklaus, Stephanie, et al.
Publicado: (2017)

Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice
por: González, Luis F., et al.
Publicado: (2017)

NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease
por: Sirabella, Rossana, et al.
Publicado: (2018)

Effects of clonidine on the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes
por: Woo, Jae Hee, et al.
Publicado: (2012)

Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache
por: Shin, Hae-Eun, et al.
Publicado: (2011)

Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
por: Magi, Simona, et al.
Publicado: (2017)

Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants
por: Rajatileka, Shavanthi, et al.
Publicado: (2017)

Remote Ischaemic Preconditioning Accelerates Brain to Blood Glutamate Efflux via EAATs-mediated Transport
por: Končekova, Jana, et al.
Publicado: (2023)

Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4
por: Almilaji, Ahmad, et al.
Publicado: (2013)

Pharmacology of Glutamate Transport in the CNS: Substrates and Inhibitors of Excitatory Amino Acid Transporters (EAATs) and the Glutamate/Cystine Exchanger System x(c)(−)
por: Bridges, Richard J., et al.
Publicado: (2008)

A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke
por: Mallolas, Judith, et al.
Publicado: (2006)

Position of the Third Na(+) Site in the Aspartate Transporter Glt(Ph) and the Human Glutamate Transporter, EAAT1
por: Bastug, Turgut, et al.
Publicado: (2012)

Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes
por: Park, Hye Jin, et al.
Publicado: (2015)

Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease
por: Takahashi, Kou, et al.
Publicado: (2015)

Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
por: Lariccia, Vincenzo, et al.
Publicado: (2020)

Patterned Neuroprotection in the Inpp4a(wbl) Mutant Mouse Cerebellum Correlates with the Expression of Eaat4
por: Sachs, Andrew J., et al.
Publicado: (2009)

Closed Gateways — Can Neuroprotectants Shield the Retina in Glaucoma?
por: Velpandian, Thirumurthy
Publicado: (2012)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
por: Hinson, Shannon R., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_mdm0i3840c0ir4sc1r0jg3990c